ACAD
Acadia Pharmaceuticals Inc
$27.52
-1.11% ($0.31)
Volume
1.63M
52W High
$30.96
52W Low
$19.69
Market Cap
$4.41B
What to Watch This Quarter
Based on historical dataConsensus EPS
$0.21
Whisper EPS
$0.22
5.4% above consensus
Last Quarter
$0.18
Current Streak
1 Beat
Avg Surprise (4Q)
+69.23%
Next Earnings Report
Reports in 49 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q2 2026
Aug 4, 2026
1-Day:
+6.08%
Q1 2026
May 13, 2026
1-Day:
-0.41%
5-Day:
-6.72%
Q1 2026
May 6, 2026
1-Day:
+5.03%
5-Day:
+1.49%
Q4 2025
Mar 2, 2026
1-Day:
-1.36%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $284.0M | +9.4% | 90.8% | 6.1% | $273.6M |
| Q3'25 | $278.6M | +11.3% | 92.2% | 12.8% | $71.8M |
| Q2'25 | $264.6M | +9.3% | 92.2% | 12.2% | $26.7M |
| Q1'25 | $244.3M | +18.7% | 91.7% | 7.9% | $19.0M |
| Q4'24 | $259.6M | +12.4% | 91.6% | 59.1% | $143.7M |
| Q3'24 | $250.4M | +18.3% | 92.5% | 12.6% | $32.8M |
| Q2'24 | $242.0M | +46.4% | 92.5% | 12.6% | $33.4M |
| Q1'24 | $205.8M | +73.8% | 88.9% | 7.4% | $16.6M |
Company Information
Symbol
ACAD
Company
Acadia Pharmaceuticals Inc
Market Cap
$4.41B
Next Earnings
Nov 4, 2026